Intramuscular (in the muscle) 22 gauge 1 inch needle
This counteraction might involve the central (i.e., encephalopathies) [15,16,17,18,50], and/or peripheral (i.e., gastrointestinal and liver lesions, bleeding disorders, and muscle disabilities) [15,16,17,18,50,87,88] adverse effects, acting as a membrane stabilizer (counteracted leaky gut) [11] and free radical scavenger, particularly in the vascular studies [10,11,55,66,75,76,79,80,89,90,91] (for illustration, see Figure 1, Figure 2, Figure 3, Figure 4, Figure 5 and Figure 6)
The most speculative
BPC-157 10mg + TB-500 10mg (Blend) The BPC-157 + TB-500 Blend adds two widely researched synthetic peptides in an equal ratio, i.e., 1:1 (10mg BPC-157 + 10mg TB-500 per vial)
I wouldnt mind betting that some of the GPs and nurses were concerned at this change in treatment being imposed upon them